LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 75,720 | 33,419 | 23,054 | 10,056 | 0 |
| Cost of Goods | 13,489 | 7,819 | 2,392 | 1,643 | N/A |
| Gross Profit | 62,231 | 25,600 | 20,662 | 8,413 | N/A |
| Operating Expenses | 40,889 | 62,257 | 130,855 | 203,107 | 115,427 |
| Operating Income | 21,831 | -35,838 | -109,801 | -194,051 | -115,427 |
| Interest Expense | 10,458 | 10,051 | 10,774 | 7,303 | 0 |
| Other Income | 8,336 | 6,468 | 4,067 | 1,885 | 624 |
| Pre-tax Income | 19,709 | -39,421 | -116,508 | -199,469 | -114,803 |
| Income Tax | 49 | 0 | N/A | N/A | N/A |
| Net Income Continuous | 19,660 | -39,421 | -116,508 | -199,469 | -114,803 |
| Net Income | $19,660 | $-39,421 | $-116,508 | $-199,469 | $-114,803 |
| EPS Basic Total Ops | 0.72 | -1.44 | -4.30 | -7.85 | -5.41 |
| EPS Basic Continuous Ops | 0.72 | -1.44 | -4.30 | -7.85 | -5.41 |
| EPS Diluted Total Ops | 0.58 | -1.44 | -4.30 | -7.85 | -5.41 |
| EPS Diluted Continuous Ops | 0.58 | -1.44 | -4.30 | -7.85 | -5.41 |
| EPS Diluted Before Non-Recurring Items | 0.58 | -1.44 | -4.30 | -7.85 | -5.41 |
| EBITDA(a) | $23,712 | $-31,754 | $-103,942 | $-189,646 | $-114,159 |